Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 4 7Phase 3 2Phase 2 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1Breast 1

Conditions

Neoplastic Cells, Circulating 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Propofol × Gastrointestinal × Clear all
NCT06017141 2023-08-30

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

University of Kansas Medical Center

Phase 2 Unknown
80 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05502458 2022-08-16

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Zhejiang Cancer Hospital

Phase 2 Completed
60 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡